7 completed. 2 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow FluLaval: new trials by email Literature Review of FluLaval trials Research Report on FluLaval
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae Cefixime, Ceftriaxone, Ciprofloxacin - Gonorrhea Male | Phase 2 | Completed | University of North Carolina, Chapel Hill | 65 | 2022-04-18 | 2026-03-02 |
| Safety of RIV4 Versus IIV4 in Pregnant Women Quadrivalent Recombinant Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccine - Safety, Adverse Event Following Immunisation | Phase 4 | Completed | Duke University | 384 | 2019-09-05 | 2023-01-11 |
| Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers Trivalent Influenza Vaccine - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Early Phase 1 | Completed | Roswell Park Cancer Institute | 130 | 2017-10-17 | 2023-06-06 |
| Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors Hepatitis A Vaccine, Laboratory Biomarker Analysis, Tetanus Toxoid Vaccine - Astrocytoma, Glioma | Completed | Wake Forest University Health Sciences | 55 | 2016-05-01 | 2021-10-29 | |
| FluMist in Egg Allergic Patients FluMist intranasal influenza vaccine, Intramuscular influenza injection ("flu shot") - Egg Allergy, Eligible for Vaccination Against Influenza | Phase 1 / Phase 2 | Completed | Walter Reed Army Medical Center | 17 | 2010-09-01 | 2018-10-03 |
| VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat... VRC-FLUDNA047-00-VP, Flulaval (Registered) Seasonal Influenza Vaccine - Influenza, Human | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 51 | 2009-03-03 | 2017-07-02 |
| Immune Responses Induced by Different Licensed Influenza Vaccines Flulaval, Fluvirin, Fluzone - Immune Response | Not applicable | Completed | University of Massachusetts, Worcester | 193 | 2008-10-01 | 2017-11-20 |
Influenza, Human (4) · Astrocytoma (1) · Egg Hypersensitivity (1) · Glioma (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1) · Oligodendroglioma (1)
Duke University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Roswell Park Cancer Institute (1) · University of Massachusetts, Worcester (1) · University of North Carolina, Chapel Hill (1) · Wake Forest University Health Sciences (1) · Walter Reed Army Medical Center (1)
United States (7)
Elizabeth A Griffiths (1) · Geeta K Swamy, MD (1) · Joseph A Duncan, MD, PhD (1) · Karen R Broder, MD (1) · Mary Dawn T Co, MD (1) · Roy Strowd (1) · Susan Laubach, MD (1)
PMID 22542645, PMID 26275339, PMID 40086037, PMID 42049314
P30CA012197 (1), U01AI162457 (1)